Carrier screens for cystic fibrosis, fragile X syndrome, and spinal muscular atrophy detected carrier status in one in 20 individuals and led to diagnoses in seven pregnancies.
HER3 mRNA expression analysis can predict colorectal cancer patients with wild-type RAS tumors who will respond to panitumumab, US and UK researchers reported.
Pillar will use its stem loop inhibition-mediated amplification technology to develop diagnostics that run on Illumina's MiSeqDx instrument.
Japanese researchers developing the method highlighted its ability to accurately and rapidly diagnose different strains of malaria in resource-limited endemic regions.
The multiplexed assay is the second available on the Panther Fusion system and the FDA is reviewing a third, the Panther Fusion AdV/hMPV/RV assay.
The test is performed on the company's AmpiProbe platform, and the approval expands Enzo's offering of infectious disease tests in New York.
The startup is launching an instrument that will process up to 10,000 single cells for DNA sequencing as well as a panel that will target AML genes.
The firm attributes the positive results to efforts to strengthen its US diagnostics business and stabilize its core diagnostics product families of H. pylori and food testing.
The firm raised €4.7 million through a conditional placement, and €5.0 million through an unconditional direct subscription.
The firm hopes its newly launched DxWound will improve pathogen detection in skin and soft tissue infections by including anaerobic and fungal microbes in its reports.
Demand for the BioFire FilmArray panels continued to drive sales in the firm's molecular biology business.
The recent study highlights strengths and weaknesses of numerous platforms and may help end users choose the best assay for their circumstances.
The test detects and differentiates respiratory syncytial virus and human metapneumovirus on the firm's Solana rapid molecular platform.
The two companies plan to secure required initial regulatory approvals in individual African territories before expanding to other areas in the region.
A new assay uses digital loop-mediated isothermal amplification (dLAMP) to perform phenotypic antibacterial susceptibility testing in 30 minutes.
The British company has announced the results of two studies showcasing the ability of its EpiSwitch platform to diagnose and stage breast cancer and ALS patients.
The test detects and differentiates norovirus genogroups I and II directly from stool without RNA extraction.
The agency cleared the automated qualitative IVD test last month for the detection of the toxin B gene of toxigenic Clostridium difficile.
Following the CE-IVD marking, Bruker launched the two products, the multiplex real-time PCR-based Fungiplex Candida assay and the Micronaut-AM test plate.
The test is intended for use by blood collection facilities and is not approved for the individual diagnosis of Zika infection.
Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.
Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.
The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.
In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.